March 4, 2025
- Michelle Forman, MSc. Biomedical Engineering (intern HERAN)
Artificial Intelligence is transforming drug development, with new approaches and trends emerging at every stage of the process. At HERAN we are interested in how these advancements shape the industry and create new opportunities.
In this paper we examine key trends, challenges, and the factors that drive value in this rapidly evolving space.